Blogs

Latest Blogs

[wd_asp id=2]

Antibody‑Drug Conjugates (ADCs): The Tipping Point

The field of antibody-drug conjugates (ADCs) is entering an exciting era, and there is no shortage of writing today about where this modality is headed:…

The STING in the tail: How our own defense mechanisms to infection may be working against us

In this latest blog, we explore this pathway, its burgeoning links to multiple diseases and how biomarker profiling can assist…

Falling drug approval rates: What should we be doing differently?

Over the years, this failure rate of drug approvals has not seen significant improvement, which begs the question - why?…

Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer

We highlight some of the exciting translational tools that have been developed to understand brain cancer and how these are…

World Multiple Sclerosis Day 2024: Wider access to crucial antibody therapies

World Preeclampsia Day 2024: A spotlight on the neurological consequences

Primary Immunodeficiency Week: The promise of gene therapy

In this blog, we delve deeper into the exciting world of gene therapy for PIDs.…

Talk to our Biomarker Experts